Memorandum from NZSG

By NZ Gastro Office | Posted: Thursday April 6, 2023

Ustekinumab is a funded medication for IBD

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website